002107.SZ SHZ
Shandong Wohua Pharmaceutical Co., Ltd.
1W: -3.3%
1M: +5.8%
3M: +11.8%
YTD: -3.0%
1Y: +2.0%
3Y: +27.8%
5Y: +2.3%
¥7.09 ($1.06)
-0.01 (-0.14%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$977M
-0.8% ▼
5Y CAGR: -6.5%
Total Liabilities
$245M
-6.9% ▼
5Y CAGR: -11.6%
Shareholders Equity
$724M
+3.8% ▲
5Y CAGR: -2.2%
Cash & Investments
$394M
+14.4% ▲
5Y CAGR: -4.4%
Total Debt
$3M
+147.8% ▲
5Y CAGR: -56.7%
Net Debt
-$392M
-13.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $327M | $278M | $401M | $345M | $394M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $327M | $278M | $401M | $345M | $394M |
| Net Receivables | $117M | $171M | $99M | $83M | $76M |
| Inventory | $166M | $146M | $149M | $107M | $93M |
| Other Current Assets | $11M | $0 | $21M | $6M | $0 |
| Total Current Assets | $621M | $599M | $673M | $543M | $567M |
| Property, Plant & Equip. | $448M | $410M | $383M | $355M | $326M |
| Goodwill & Intangibles | $87M | $69M | $69M | $68M | $67M |
| Long-Term Investments | $0 | $19M | $18M | $18M | $17M |
| Other Non-Current Assets | $3M | $2M | $272K | $393K | $0 |
| Total Non-Current Assets | $541M | $501M | $472M | $443M | $411M |
| Total Assets | $1.2B | $1.1B | $1.1B | $986M | $977M |
| — Liabilities — | |||||
| Accounts Payable | $27M | $45M | $53M | $42M | $39M |
| Short-Term Debt | $3M | $277K | $3M | $0 | $2M |
| Deferred Revenue | $6M | $12M | $0 | $0 | $5M |
| Other Current Liabilities | $169M | $225M | $168M | $146M | $179M |
| Total Current Liabilities | $204M | $283M | $288M | $242M | $241M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $233K |
| Other Non-Current Liab. | $578K | $1M | $725K | $210K | $65K |
| Total Non-Current Liabilities | $28M | $27M | $23M | $21M | $4M |
| Total Liabilities | $232M | $310M | $311M | $263M | $245M |
| — Equity — | |||||
| Common Stock | $577M | $577M | $577M | $577M | $577M |
| Retained Earnings | $184M | $130M | $184M | $74M | $85M |
| Accumulated OCI | $60M | $40M | $44M | $0 | $62M |
| Total Stockholders Equity | $821M | $747M | $805M | $697M | $724M |
| Total Liabilities & Equity | $1.2B | $1.1B | $1.1B | $986M | $977M |
| — Key Metrics — | |||||
| Total Debt | $3M | $1M | $3M | $1M | $3M |
| Net Debt | -$324M | -$277M | -$401M | -$344M | -$392M |
| Total Investments | $0 | $19M | $18M | $18M | $17M |